产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
名称 | BxPC-3 (人原位胰腺腺癌细胞) (STR鉴定正确) |
别称 | BxPc-3; BXPC-3; Bx-PC3; BXPC3; BxPC3; BxPc3; Biopsy xenograft of Pancreatic Carcinoma line-3 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
生长培养基 | RPMI-1640+10% FBS+1% P/S |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养条件 | 气相:空气,95%;CO2,5% 温度:37℃ |
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2~3次/周 |
背景描述 | BxPC-3细胞不表达囊肿性纤维化跨膜电导调节子(CFTR),CFTR阳性的细胞株是Capan-1。 |
年龄(性别) | 女;61岁 |
组织来源 | 胰腺;腺癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 胰腺癌细胞 |
生物安全等级 | 1 |
倍增时间 | ~48-60 hours |
致瘤性 | Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 1×10^7 cells. |
基因表达情况 | mucin; pancreas cancer specific antigen (pancreas cancer associated antigen); carcinoembryonic antigen (CEA) |
保藏机构 | ATCC; CRL-1687 BCRC; 60283 BCRJ; 0056 DSMZ; ACC-760 ECACC; 93120816 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 13 D2S1338 17,19 D3S1358 14,16 D5S818 11 D7S820 10,13 D8S1179 13 D13S317 11 D16S539 9,11 D18S51 12 D19S433 13,16.2 D21S11 29 FGA 20,21 PentaD 14 PentaE 12,14 TH01 9 TPOX 8 vWA 14,18 D6S1043 12 D12S391 19.3,20 D2S441 12,14 -
STR鉴定图
-
参考文献
-
Biomimetic camouflaged nanoparticle-based folfirinox platform for optimizing clinical pancreatic cancer treatment(2022/12/21)
作者:Qian Wang, Zihua Wang, Zhangfu Li
期刊:Nano Today
DOI:10.1016/j.nantod.2022.101733
影响因子 :17.400
引用产品:CL-0042
-
ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway(2022/04/07)
作者:Ma Zuyi, Li Zhenchong, Wang Shujie
期刊:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI:10.1186/s13046-022-02310-8
影响因子 :11.300
-
Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer(2022/08/04)
作者:Lei Dou, Huiqin Liu, Kaixin Wang
期刊:JOURNAL OF CONTROLLED RELEASE
DOI:10.1016/j.jconrel.2022.07.033
影响因子 :10.800
-
Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer(2022/12/10)
作者:Xiaoyan Yang, Jinguo Zhang, Qiaomei Zhou
期刊:JOURNAL OF NANOBIOTECHNOLOGY
DOI:10.1186/s12951-022-01738-6
影响因子 :10.200
-
Radionuclide labeled nanocarrier for imaging guided combined radionuclide, sonodynamic, and photothermal therapy of pancreatic tumours(2023/03/30)
作者:Jie An, Xinyi He, Huizhu Ma
期刊:JOURNAL OF COLLOID AND INTERFACE SCIENCE
DOI:10.1016/j.jcis.2023.03.111
影响因子 :9.900
引用产品:CL-0042
-
SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis(2021/07/24)
作者:Dianyun Ren, Yan Sun, Dan Zhang
期刊:Cancer Letters
DOI:10.1016/j.canlet.2021.07.035
影响因子 :9.700
-
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation(2023/03/28)
作者:Chengjie Lin, Ting Li, Yan Wang
期刊:Cell Death & Disease
DOI:10.1038/s41419-023-05715-1
影响因子 :9.000
-
GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments(2021/08/30)
作者:Yueqin Feng, Yuguan Jiang, Fengjin Hao
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-021-03050-7
影响因子 :7.400
引用产品:CL-0042
-
Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy(2023/06/27)
作者:Yanlong Shi, Yizhu Wang, Hui Dong
期刊:APOPTOSIS
DOI:10.1007/s10495-023-01868-8
影响因子 :7.200
-
Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2(2022/09/20)
作者:Meijie Chen, Xuena Li, Bulin Du
期刊:BIOCHEMICAL PHARMACOLOGY
影响因子 :5.800
引用产品:CL-0027 CL-0042 CL-0059 CL-0184 CL-0448A CL-0627 CM-0059 CM-0448A
-
RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines(2023/02/08)
作者:Hui Dong, Haidong Zhang, Xinyu Mao
期刊:Cancers
影响因子 :5.200
-
COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation(2023/02/26)
作者:Yao Song, Lei Wang, Kaidong Wang
期刊:Cancers
影响因子 :5.200
-
Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research(2022/01/08)
作者:Zhenghai Bai, Fangshi Xu, Xiaodan Feng
期刊:Bioengineered
DOI:10.1080/21655979.2021.2019873
影响因子 :4.900
-
CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer(2021/08/03)
作者:Zixuan Zhou, Zuyi Ma, Zhenchong Li
期刊:Journal of Cancer
影响因子 :3.900
-
IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway(2022/01/17)
作者:X-Y Shi, X-L Zhang, Q-Y Shi
期刊:Clinical & Translational Oncology
DOI:10.1007/s12094-021-02748-w
影响因子 :3.400
引用产品:CL-0042
-
Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway(2020/3/10)
作者:Xiangpeng Meng, Jia Ma, Baosheng Wang
期刊:Journal Of Physiology And Biochemistry
DOI:10.1007/s13105-020-00734-4
影响因子 :3.400
-
Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer(2023/02/12)
作者:Jiaxing Du, Yongsheng Chen, Genglong Liu
期刊:PATHOLOGY RESEARCH AND PRACTICE
影响因子 :2.800